Coronavirus Related Content

Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.

European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.

US and UK researchers examined ethnicity data in both countries, finding that Black and Asian people were twice as likely as white people to be infected by the virus - but why?

While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.

Under new Government guidance, university students will be allowed to travel home for Christmas on staggered departure dates to reduce the risk of COVID-19 transmission.

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.

Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.

Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.

Emily Malcolm from Toybox argues that empowering mothers of street children through business has important ripple effects to change the future for generations to come in this fascinating poverty focus.

Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.

Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.

Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.

The study showed that fear of dwindling resources and job insecurity could distract individuals from following COVID-19 regulations for Americans across 43 states.

Dr Gabriela Whitehead, Head of Digital Transformation and Process Management at GISMA Business School turns the spotlight on recruitment during COVID-19, including comment on managing resources.

Chancellor Rishi Sunak has announced that the government's furlough scheme will be extended until the end of March.

A West Midlands company has just been appointed the UK’s official dental and care home distributor of the Coronavirus killing robot called THOR UVC®.

Rosie Evans, Behavioural Scientist at CoachHub, discusses the cognitive changes caused by working from home and shares her behavioural strategies for making sure that both remote and on-site teams are able to collaborate, engage, and work as well as they do in person.

Abdullah Sabyah, Founder and CEO Rightangled, discusses the need to overhaul the government’s approach to coronavirus testing in schools and explores how home-based private testing can ensure children continue to receive the education they need.